ROSEN, A TOP RANKED LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESONewsfile Corp • 10/22/20
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mesoblast Limited (MESO)PRNewsWire • 10/22/20
Randomized Controlled Study Using Direct Injection of Remestemcel-L Into Inflamed Gut of Patients With Crohn's Disease and Ulcerative ColitisGlobeNewsWire • 10/22/20
MESO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020Business Wire • 10/20/20
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mesoblast Limited (MESO)Business Wire • 10/19/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action– MESOBusiness Wire • 10/16/20
ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm – MESOBusiness Wire • 10/15/20
Notice of Lead Plaintiff Deadline for Shareholders in the Mesoblast Limited Class Action LawsuitBusiness Wire • 10/14/20
Are Options Traders Betting on a Big Move in Mesoblast (MESO) Stock?Zacks Investment Research • 10/14/20
MESO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Mesoblast Limited Shareholders of Class Action and Lead Plaintiff Deadline: December 7, 2020PRNewsWire • 10/13/20
Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% EnrollmentGlobeNewsWire • 10/13/20
Rosen, Globally Respected Investor Counsel, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 10/12/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/12/20
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 10/09/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mesoblast Limited (MESO) InvestorsBusiness Wire • 10/09/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/09/20
Mesoblast Needs A Solution To MSC Scalability Issues - Cynata Therapeutics Has An AnswerSeeking Alpha • 10/09/20
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm – MESOBusiness Wire • 10/09/20
MESO CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Mesoblast Limited (MESO)Business Wire • 10/09/20
MESO CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Mesoblast LimitedBusiness Wire • 10/08/20
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/07/20
Glancy Prongay & Murray LLP Continues Investigation on Behalf of Mesoblast Limited (MESO) InvestorsBusiness Wire • 10/06/20
The Law Offices of Frank R. Cruz Continues Its Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/06/20
The Law Offices of Frank R. Cruz Announces Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/05/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mesoblast Limited (MESO) on Behalf of InvestorsBusiness Wire • 10/05/20
